Developer docs
API playgroundTry for free, no card

Search company profiles

Genobank.io

Full company profile

uuid0003bq9

Namestring
Genobank.io
Legal namestring
GenoBank.io Inc.
Websiteurl
genobank.io
Company typeenum
Private
Founded yearint
2020
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSan Mateo, United States
HQ citystring
San Mateo
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
genomic data ownership, blockchain genomics, patient-owned DNA, DNA testing kit, genomic IP licensing
Industry6 codes
PRIMARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
SECONDARYHLALAHAK
Genetic Counseling & Prenatal Testing Telehealth (carrier screening, NIPT counseling)
Healthcare & Life Sciences/Telehealth Platforms/Women’s & Family Health Telehealth Platforms (fertility, pregnancy, pediatrics)
SECONDARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
SECONDARYHLAGAEAD
Genomics & Molecular Diagnostics (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAGAJAH
Sample / Biorepository & Biobank Informatics (Chain-of-Custody)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACAMAG
Biobank & Biospecimen Management LIMS
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics
NAICS code3 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code3 codes
  • Services-Medical Laboratories8071
  • Patent Owners & Lessors6794
  • Services-Commercial Physical & Biological Research8731
Product category
Blockchain Genomics Platform
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model4 records
1GenoClaw DNA Kit Sales
TypeHardware Sales
Description

One-time sale of the GenoClaw Kit at $499 per unit (pre-sale), including 30x whole-exome sequencing at a CLIA-certified US lab, raw FASTQ/BAM/VCF file delivery, numbered BioNFT on Sequentia, GenoClaw AI agent on encrypted USB, MyChart integration, lifetime BioVault access, and free US shipping. No subscription required for core kit functionality.

genobank.io
2Cloud BioVault Subscription
TypeSubscription Recurring
Description

Optional $9/month Cloud BioVault subscription providing encrypted sandbox for mobile/tablet access to genome, monthly variant re-analysis as new research drops, physician-ready PDF export, and family sharing for up to 4 BioNFTs. Billed only after kit ships; cancelable anytime.

genobank.io
3Story Protocol Genomic IP Licensing
TypeLicensing Royalties
Description

Patients can optionally license their BioNFT genomic data via Story Protocol's Programmable IP License (BioPIL) to researchers. Revenue from license fees is automatically distributed to data owners, analysis service providers, and the Story Protocol treasury per license terms. Opt-in only; default state is 'off the market'.

genobank.io
4x402 BioData Router Micropayments
TypeTransaction Fee
Description

Coinbase x402 HTTP-native payment protocol enables agent-to-agent micropayments for genomic data access and analysis across the decentralized biobank network. Data commerce flows through the BioData Router smart contract with Byzantine-fault-tolerant quality assurance.

genobank.io
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Pricing details2 tiers
1GenoClaw Kit Edition 01 — one-time purchase DNA kit with AI agent
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$499 once (pre-sale, regular $899). Includes 30x whole-exome sequencing, raw FASTQ/BAM/VCF files (yours forever), numbered BioNFT on Sequentia (kits 001-100), GenoClaw AI agent on encrypted USB drive, MyChart integration via Epic FHIR R4, lifetime BioVault access, and free US shipping. Ships late May 2026. Limited to 100 numbered kits.

genobank.io
2Cloud BioVault — optional encrypted cloud access add-on
ModelSubscriptionBilling cadenceMonthly
Notes

$9/month. Encrypted sandbox for querying genome from phone/tablet/laptop. Monthly variant re-analysis as new research emerges. Physician-ready PDF export. Family sharing up to 4 BioNFTs. Only billed after kit ships. Cancel anytime.

genobank.io
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Brand1 of 12 records shown
1GenoVault
Description

Patient-owned health and genomic data vault with blockchain-verified consent management

genobank.io
+11 more records
Core offering1 text field

GenoBank.io operates a patient-owned genomic data platform that converts physical DNA samples into patented BioNFTs (US Patents 11,984,203 B1 and 11,915,808 B1) on its Sequentia Layer-1 blockchain, enabling patients to control, license, and revoke access to their genetic data. The company sells a direct-to-consumer GenoClaw DNA Kit ($499 pre-sale) that includes 30x whole-exome sequencing, a local AI agent, and Tangem NFC wallet, plus a $9/month Cloud BioVault subscription. It also offers laboratory certificates, partner lab onboarding (52 organizations across 8+ countries), and Story Protocol-based BioIP licensing to researchers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 7,000+ patients have created GenoVaults and control their genomic data on-chain with full sovereignty
+3 more records
Product overview1 text field

GenoBank.io is a patient-owned genomic data platform built on blockchain technology, offering a modular ecosystem of products centered on the BioNFT (US Patents 11,984,203 B1 and 11,915,808 B1) — a tokenized biosample system that gives patients verifiable blockchain ownership of their genomic data. The core platform (GenoBank.io) powers 7,000+ GenoVaults with 150+ research partnerships and $6.9M+ tokenized BioIP value. The product portfolio includes: GenoVault personal data dashboard, OpenCRAVAT variant annotation (220+ sources), SOMOS DAO ancestry analysis, AlphaGenome AI pathogenicity scoring, and the GenoClaw Kit (Edition 01 pre-sale, $499, shipping May 2026) featuring 30x whole-exome sequencing, a local GenoClaw AI agent, and Tangem NFC card for wallet-free BioNFT minting. The Sequentia blockchain (Chain ID: 15132025) serves as the underlying infrastructure, while Story Protocol enables BioPIL programmable IP licensing. All genomic services connect via Epic FHIR R4 for clinical records, and Anthropic Claude provides AI-powered genomic interpretation.

Product and service6 records
1GenoClaw Kit
CategoryDirect-to-consumer DNA testing kit
Description

World's first AI-friendly DTC DNA kit combining 30x whole-exome sequencing at a CLIA-certified US lab, raw FASTQ/BAM/VCF file delivery, a numbered BioNFT on Sequentia, GenoClaw local AI agent on encrypted USB drive, MyChart integration via Epic FHIR R4, lifetime BioVault access, free US shipping, and a Tangem NFC card for wallet-free BioNFT minting. For health-conscious individuals and rare-disease patients seeking AI-friendly personal genomics with full data ownership.

2Cloud BioVault
CategorySubscription add-on
Description

Optional $9/month encrypted cloud sandbox subscription for GenoClaw Kit customers, enabling mobile/tablet/laptop genome querying, monthly variant re-analysis as new research emerges, physician-ready PDF export, and family sharing for up to 4 BioNFTs. Billed only after the kit ships and cancelable anytime.

3GenoBank.io Platform (GenoVault Dashboard)
CategoryPatient-owned genomic data platform
Description

Patient-owned genomic data platform with the GenoVault personal dashboard where individuals store, manage, and control access to VCF/BAM/FASTQ genomic files, FHIR clinical records, and biosample metadata via blockchain-verified consent and BioNFT technology. Supports 7,000+ GenoVaults, 150+ research partnerships, and $6.9M+ tokenized BioIP value across the platform.

4Laboratory Certificates
CategoryLaboratory certification service
Description

Blockchain-certified laboratory test results with QR code verification, accepted by the US Department of Homeland Security for travel. Enables laboratories to create verifiable certificates with immutable on-chain records and QR-code-based authenticity verification for COVID-19 and other diagnostic test results.

5BioIP Licensing on Story Protocol (BioPIL)
CategoryGenomic IP licensing marketplace
Description

Optional genomic IP licensing service built on Story Protocol blockchain (Chain ID 1500) that enables patients to wrap their BioNFTs as programmable IP Assets with revocable BioPIL license terms, and researchers to acquire licenses programmatically with automatic revenue distribution to data owners, analysis providers, and the Story Protocol treasury. Default state is opt-out ('off the market').

6Sequentia Network
CategoryBlockchain infrastructure
Description

Specialized Layer-1 blockchain (Chain ID 15132025) built on Ethereum Clique Proof-of-Authority consensus, purpose-built for genomic data federation, bioinformatics computation, and programmable IP licensing. Features deterministic 15-second block times, EVM compatibility, BioData Router smart contract, LabNFT identity tokens, BioNFT biosample tokens, and a partner chain ecosystem. Master node operated at 52.90.163.112.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership16 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-01-01
Description

Story Protocol (Chain ID: 1500) is the blockchain infrastructure for genomic intellectual property management on GenoBank.io. Every genomic file registered on Sequentia can be registered as a Story Protocol IP Asset with programmable BioPIL license terms. Revenue from license fees is automatically distributed to data owners via Story's licensing smart contracts. This is the core monetization layer for patient-owned genomic IP.

Strategic tierCoreTypeTechnology or Integration
Description

Avalanche C-Chain (Chain ID: 43114) handles primary blockchain operations for smart contract execution, providing fast, secure transactions with Avalanche C-Chain redundancy alongside Sequentia Network. Used for BioNFT minting, consent transactions, and smart contract governance.

Strategic tierCoreTypeTechnology or Integration
Description

The InterPlanetary File System provides decentralized, distributed genomic file storage for GenoBank.io. Files are content-addressed by cryptographic hash, ensuring data integrity. All genomic data is encrypted before storage on IPFS. Access is controlled through the GenoBank IPFS gateway (ipfs.genobank.app) requiring blockchain authentication.

Strategic tierCoreTypeTechnology or Integration
Description

GenoBank.io is a registered Epic third-party app enabling SMART-on-FHIR OAuth2 connectivity across 65,000+ US hospitals. Patients authorize read-only access to their hospital's MyChart; GenoBank never receives portal credentials. Supports import of Patient, Condition, MedicationRequest, Observation, AllergyIntolerance, Immunization, Procedure, DiagnosticReport, DocumentReference, Encounter FHIR R4 resources.

5OpenCRAVAT
Strategic tierCoreTypeTechnology or Integration
Description

OpenCRAVAT is a decentralized genomic variant annotation network integrated as a Sequentia Network partner chain. Instead of centralized servers, annotation jobs are distributed across nodes. Features 220+ annotation sources (ClinVar, gnomAD, COSMIC), modular annotator system, SQLite output, and expert curator AI integration. Integration with GenoBank BioFS Protocol for consent-gated variant annotation.

genobank.io
6AlphaGenome (DeepMind AlphaMissense)
Strategic tierCoreTypeTechnology or Integration
Description

AlphaGenome leverages DeepMind's AlphaMissense model for variant pathogenicity prediction via API. Results are tokenized and linked to parent VCF as derivative IP assets on Sequentia/Story Protocol. Provides pathogenicity scores (0-1) for genomic variants, enabling clinical interpretation of variants of uncertain significance.

genobank.io
Strategic tierCoreTypeTechnology or Integration
Description

Claude AI (Anthropic) provides AI-powered genomic analysis integrated into GenoBank.io. Powers the GenoClaw AI agent (local-first), the GenoBank web app AI assistant for families and researchers, and multi-agent adversarial co-interpretation workflows. All AI interactions are logged on-chain for auditability. No data retention by Anthropic.

8SOMOS DAO
Strategic tierCoreTypeTechnology or Integration
Description

SOMOS DAO provides ancestry composition analysis as a Sequentia partner chain. Accepts 23andMe, Ancestry.com, and VCF file inputs. Processing runs via ECS Fargate container (10-15 minutes), outputting a 24-population ancestry breakdown plus haplogroups. Results are tokenized as an ancestry NFT with Story Protocol licensing.

genobank.io
Strategic tierSecondaryTypeTechnology or Integration
Description

AlphaFold integration enables variant-to-protein structure prediction as a Sequentia partner chain service. Pipeline: Variant → Protein sequence change → AlphaFold 3D structure prediction → Structural impact analysis. Enables assessment of whether genetic variants cause structural protein disruption.

Strategic tierSecondaryTypeTechnology or Integration
Description

World ID integration enables proof-of-personhood verification to be added to GenoBank.io's BioWallet — the world's first decentralized laboratory ID. Enables users to prove they are human (without revealing identity) when registering biosamples, licensing genomic data, or recovering lost credentials via DNA.

Strategic tierSecondaryTypeTechnology or Integration
Description

Tangem NFC card included with GenoClaw Kit. Users tap the Tangem Card to their phone to mint their BioNFT via NFC — no crypto wallet setup required. The Tangem Card handles the wallet infrastructure, making Web3 genomics accessible to non-crypto-native consumers.

12Magic (Google OAuth Bridge)
Strategic tierSecondaryTypeTechnology or Integration
Description

Magic provides OAuth-to-Web3 authentication bridge enabling users to sign in with their Google account, which Magic converts to a Web3 wallet. Supports MetaMask, GenoBank BioWallet, and Magic for wallet-based authentication. Reduces friction for non-crypto-native users onboarding to the platform.

genobank.io
Strategic tierSecondaryTypeTechnology or Integration
Description

Coinbase's x402 HTTP-native payment protocol enables agent-to-agent micropayments for genomic data access and analysis across the decentralized biobank network. The x402 BioData Router provides Byzantine-fault-tolerant quality assurance for automated data commerce between AI agents and data providers.

14NiMEDix (Nigeria)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

NiMEDix is a Nigerian blockchain/AI company focused on bridging gaps in remittances, healthcare funding collaboration, and healthcare access services. Announced June 2021 as a strategic partnership for healthcare blockchain expansion in Africa.

genobank.io
15Bustamante Lab (Florida)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Bustamante Lab is a research and development laboratory in Hialeah, Florida. Announced as a GenoBank.io partnership in June 2021 for blockchain-enabled laboratory services and COVID-19 testing verification.

genobank.io
16Government of Quintana Roo (Mexico)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

GenoBank.io partnered with the Government of the State of Quintana Roo, Mexico to verify authenticity of COVID-19 test results using the Avalanche blockchain platform. Combatting test fraud was the primary use case for this government partnership.

genobank.io
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
1AncestryDNA
TypeBroad incumbent
Description

World's largest consumer DNA network with 20M+ users, focused on genealogy and increasingly health. Listed by GenoBank.io as a recognized DTC data source; competes for the same consumer genomic-data mindshare that GenoBank.io targets.

TypeDirect peer
Description

Whole-genome sequencing provider selling DTC WGS kits internationally. Listed in GenoBank.io's recognized data catalog; competes for the same price-conscious WGS consumer that GenoClaw targets with 30x WES at $499.

TypeBroad incumbent
Description

Pioneer in direct-to-consumer genetic testing with a massive consented database. GenoBank.io itself lists 23andMe as a recognized data source in its GenoBank catalog, positioning it as both a competitor (DTC genomics) and an integration partner for legacy data portability.

TypeDirect peer
Description

Whole-genome sequencing DTC company co-founded by George Church that emphasizes privacy-preserving, blockchain-based access to genomic data. Closest direct comparator to GenoBank.io given its explicit use of blockchain for genomic data control and similar WGS + AI-agent positioning.

TypeEmerging player
Description

Genetic genealogy and ancestry testing company. Listed in GenoBank.io's recognized data catalog; competes for the same ancestry-curious consumer that SOMOS DAO serves.

TypeDirect peer
Description

Whole-genome sequencing provider with explicit positioning around consumer ownership of genetic data. Listed as a recognized GenoBank.io data source; competes in the premium WGS tier that GenoClaw Kit Edition 01 also targets.

TypeEmerging player
Description

Clinical-grade genetic testing company offering hereditary cancer, cardiovascular, and pharmacogenomics panels. Competes for the same health-conscious consumer segment that GenoClaw Kit positions for cancer-risk and PGx skills.

TypeBroad incumbent
Description

Leading medical genetics company offering clinical-grade genetic testing across multiple specialties. Listed in GenoBank.io's DTC ecosystem and shares the same CLIA-certified lab ecosystem that GenoBank.io's LabNFT infrastructure verifies on-chain.

TypeRegional player
Description

Genetic testing service with strong European user base and family-tree integrations. Comparable to GenoBank.io's international lab network ambition and a likely data-import target for GenoVault users outside the US Edition 01 footprint.

TypeEmerging player
Description

DTC genomics platform with an app-driven DNA marketplace model. Listed in GenoBank.io's recognized catalog and shares the marketplace-style approach to genomic data applications.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat7 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration21 records

Each record includes

Title, Type, Description, Source

AI capability10 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature11 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance14 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Genobank.io

Blockchain Genomics Platformgenobank.io

Genobank.io firmographics

Firmographics
Name
Genobank.io
Legal name
GenoBank.io Inc.
Website
https://genobank.io
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Genobank.io industry classification

Industry
Product category
Blockchain Genomics Platform
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Medical Laboratories (8071), Patent Owners & Lessors (6794), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
SECONDARYHLALAHAK
Genetic Counseling & Prenatal Testing Telehealth (carrier screening, NIPT counseling)
Healthcare & Life Sciences/Telehealth Platforms/Women’s & Family Health Telehealth Platforms (fertility, pregnancy, pediatrics)
SECONDARYHLAFAMAE
Molecular Diagnostics & Genomics Laboratories
SECONDARYHLAGAEAD
Genomics & Molecular Diagnostics (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAGAJAH
Sample / Biorepository & Biobank Informatics (Chain-of-Custody)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACAMAG
Biobank & Biospecimen Management LIMS
Healthcare & Life Sciences/Digital Health & Health IT/Laboratory Information Systems (LIS/LIMS) & Pathology Informatics

Keywords

  • Genomic data ownership
  • Blockchain genomics
  • Patient-owned DNA
  • DNA testing kit
  • Genomic IP licensing

Where Genobank.io is headquartered

Location

Headquarters

HQ city
San Mateo
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Genobank.io business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. GenoClaw DNA Kit Sales: One-time sale of the GenoClaw Kit at $499 per unit (pre-sale), including 30x whole-exome sequencing at a CLIA-certified US lab, raw FASTQ/BAM/VCF file delivery, numbered BioNFT on Sequentia, GenoClaw AI agent on encrypted USB, MyChart integration, lifetime BioVault access, and free US shipping. No subscription required for core kit functionality.
  2. Cloud BioVault Subscription: Optional $9/month Cloud BioVault subscription providing encrypted sandbox for mobile/tablet access to genome, monthly variant re-analysis as new research drops, physician-ready PDF export, and family sharing for up to 4 BioNFTs. Billed only after kit ships; cancelable anytime.
  3. Story Protocol Genomic IP Licensing: Patients can optionally license their BioNFT genomic data via Story Protocol's Programmable IP License (BioPIL) to researchers. Revenue from license fees is automatically distributed to data owners, analysis service providers, and the Story Protocol treasury per license terms. Opt-in only; default state is 'off the market'.
  4. x402 BioData Router Micropayments: Coinbase x402 HTTP-native payment protocol enables agent-to-agent micropayments for genomic data access and analysis across the decentralized biobank network. Data commerce flows through the BioData Router smart contract with Byzantine-fault-tolerant quality assurance.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goGenoClaw Kit Edition 01 — one-time purchase DNA kit with AI agent
SubscriptionMonthlyCloud BioVault — optional encrypted cloud access add-on

Go-to-market motion4 records

Distribution channels5 records

Marketing channels8 records

Genobank.io product offering

Product offering

Core offering

GenoBank.io operates a patient-owned genomic data platform that converts physical DNA samples into patented BioNFTs (US Patents 11,984,203 B1 and 11,915,808 B1) on its Sequentia Layer-1 blockchain, enabling patients to control, license, and revoke access to their genetic data. The company sells a direct-to-consumer GenoClaw DNA Kit ($499 pre-sale) that includes 30x whole-exome sequencing, a local AI agent, and Tangem NFC wallet, plus a $9/month Cloud BioVault subscription. It also offers laboratory certificates, partner lab onboarding (52 organizations across 8+ countries), and Story Protocol-based BioIP licensing to researchers.

Product overview

GenoBank.io is a patient-owned genomic data platform built on blockchain technology, offering a modular ecosystem of products centered on the BioNFT (US Patents 11,984,203 B1 and 11,915,808 B1) — a tokenized biosample system that gives patients verifiable blockchain ownership of their genomic data. The core platform (GenoBank.io) powers 7,000+ GenoVaults with 150+ research partnerships and $6.9M+ tokenized BioIP value. The product portfolio includes: GenoVault personal data dashboard, OpenCRAVAT variant annotation (220+ sources), SOMOS DAO ancestry analysis, AlphaGenome AI pathogenicity scoring, and the GenoClaw Kit (Edition 01 pre-sale, $499, shipping May 2026) featuring 30x whole-exome sequencing, a local GenoClaw AI agent, and Tangem NFC card for wallet-free BioNFT minting. The Sequentia blockchain (Chain ID: 15132025) serves as the underlying infrastructure, while Story Protocol enables BioPIL programmable IP licensing. All genomic services connect via Epic FHIR R4 for clinical records, and Anthropic Claude provides AI-powered genomic interpretation.

Differentiator

Problem solved

Functional benefit

Brands

  • GenoVault: Patient-owned health and genomic data vault with blockchain-verified consent management
  • GenoClaw
  • SOMOS DAO
  • BioNFT
  • BioIP
  • Sequentia Network
  • BioFS Protocol
  • BioRouter
  • BioVault
  • OpenCRAVAT
  • AlphaGenome
  • Clara AI

Products and services

  • GenoClaw Kit World's first AI-friendly DTC DNA kit combining 30x whole-exome sequencing at a CLIA-certified US lab, raw FASTQ/BAM/VCF file delivery, a numbered BioNFT on Sequentia, GenoClaw local AI agent on encrypted USB drive, MyChart integration via Epic FHIR R4, lifetime BioVault access, free US shipping, and a Tangem NFC card for wallet-free BioNFT minting. For health-conscious individuals and rare-disease patients seeking AI-friendly personal genomics with full data ownership.
  • Cloud BioVault Optional $9/month encrypted cloud sandbox subscription for GenoClaw Kit customers, enabling mobile/tablet/laptop genome querying, monthly variant re-analysis as new research emerges, physician-ready PDF export, and family sharing for up to 4 BioNFTs. Billed only after the kit ships and cancelable anytime.
  • GenoBank.io Platform (GenoVault Dashboard) Patient-owned genomic data platform with the GenoVault personal dashboard where individuals store, manage, and control access to VCF/BAM/FASTQ genomic files, FHIR clinical records, and biosample metadata via blockchain-verified consent and BioNFT technology. Supports 7,000+ GenoVaults, 150+ research partnerships, and $6.9M+ tokenized BioIP value across the platform.
  • Laboratory Certificates Blockchain-certified laboratory test results with QR code verification, accepted by the US Department of Homeland Security for travel. Enables laboratories to create verifiable certificates with immutable on-chain records and QR-code-based authenticity verification for COVID-19 and other diagnostic test results.
  • BioIP Licensing on Story Protocol (BioPIL) Optional genomic IP licensing service built on Story Protocol blockchain (Chain ID 1500) that enables patients to wrap their BioNFTs as programmable IP Assets with revocable BioPIL license terms, and researchers to acquire licenses programmatically with automatic revenue distribution to data owners, analysis providers, and the Story Protocol treasury. Default state is opt-out ('off the market').
  • Sequentia Network Specialized Layer-1 blockchain (Chain ID 15132025) built on Ethereum Clique Proof-of-Authority consensus, purpose-built for genomic data federation, bioinformatics computation, and programmable IP licensing. Features deterministic 15-second block times, EVM compatibility, BioData Router smart contract, LabNFT identity tokens, BioNFT biosample tokens, and a partner chain ecosystem. Master node operated at 52.90.163.112.

Quantifiable outcome

  • 7,000+ patients have created GenoVaults and control their genomic data on-chain with full sovereignty
  • +3 more outcomes

Companies that use Genobank.io

Customer profile

Named customers11 records

Segments3 records

Ideal customer profiles3 records

Genobank.io technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration21 records

AI capability10 records

Feature11 records

Genobank.io partnerships and signals

Strategic signal

Partnerships

16 partnerships are on record, tiered core, secondary and minor.

  • Story ProtocolcoreTechnology or Integration · 1 January 2024Story Protocol (Chain ID: 1500) is the blockchain infrastructure for genomic intellectual property management on GenoBank.io. Every genomic file registered on Sequentia can be registered as a Story Protocol IP Asset with programmable BioPIL license terms. Revenue from license fees is automatically distributed to data owners via Story's licensing smart contracts. This is the core monetization layer for patient-owned genomic IP.
  • Avalanche NetworkcoreTechnology or IntegrationAvalanche C-Chain (Chain ID: 43114) handles primary blockchain operations for smart contract execution, providing fast, secure transactions with Avalanche C-Chain redundancy alongside Sequentia Network. Used for BioNFT minting, consent transactions, and smart contract governance.
  • IPFS NetworkcoreTechnology or IntegrationThe InterPlanetary File System provides decentralized, distributed genomic file storage for GenoBank.io. Files are content-addressed by cryptographic hash, ensuring data integrity. All genomic data is encrypted before storage on IPFS. Access is controlled through the GenoBank IPFS gateway (ipfs.genobank.app) requiring blockchain authentication.
  • Epic (FHIR R4 / SMART-on-FHIR)coreTechnology or IntegrationGenoBank.io is a registered Epic third-party app enabling SMART-on-FHIR OAuth2 connectivity across 65,000+ US hospitals. Patients authorize read-only access to their hospital's MyChart; GenoBank never receives portal credentials. Supports import of Patient, Condition, MedicationRequest, Observation, AllergyIntolerance, Immunization, Procedure, DiagnosticReport, DocumentReference, Encounter FHIR R4 resources.
  • OpenCRAVATcoreTechnology or IntegrationOpenCRAVAT is a decentralized genomic variant annotation network integrated as a Sequentia Network partner chain. Instead of centralized servers, annotation jobs are distributed across nodes. Features 220+ annotation sources (ClinVar, gnomAD, COSMIC), modular annotator system, SQLite output, and expert curator AI integration. Integration with GenoBank BioFS Protocol for consent-gated variant annotation.
  • AlphaGenome (DeepMind AlphaMissense)coreTechnology or IntegrationAlphaGenome leverages DeepMind's AlphaMissense model for variant pathogenicity prediction via API. Results are tokenized and linked to parent VCF as derivative IP assets on Sequentia/Story Protocol. Provides pathogenicity scores (0-1) for genomic variants, enabling clinical interpretation of variants of uncertain significance.
  • Anthropic Claude AIcoreTechnology or IntegrationClaude AI (Anthropic) provides AI-powered genomic analysis integrated into GenoBank.io. Powers the GenoClaw AI agent (local-first), the GenoBank web app AI assistant for families and researchers, and multi-agent adversarial co-interpretation workflows. All AI interactions are logged on-chain for auditability. No data retention by Anthropic.
  • SOMOS DAOcoreTechnology or IntegrationSOMOS DAO provides ancestry composition analysis as a Sequentia partner chain. Accepts 23andMe, Ancestry.com, and VCF file inputs. Processing runs via ECS Fargate container (10-15 minutes), outputting a 24-population ancestry breakdown plus haplogroups. Results are tokenized as an ancestry NFT with Story Protocol licensing.
  • AlphaFoldsecondaryTechnology or IntegrationAlphaFold integration enables variant-to-protein structure prediction as a Sequentia partner chain service. Pipeline: Variant → Protein sequence change → AlphaFold 3D structure prediction → Structural impact analysis. Enables assessment of whether genetic variants cause structural protein disruption.
  • Worldcoin / World IDsecondaryTechnology or IntegrationWorld ID integration enables proof-of-personhood verification to be added to GenoBank.io's BioWallet — the world's first decentralized laboratory ID. Enables users to prove they are human (without revealing identity) when registering biosamples, licensing genomic data, or recovering lost credentials via DNA.
  • TangemsecondaryTechnology or IntegrationTangem NFC card included with GenoClaw Kit. Users tap the Tangem Card to their phone to mint their BioNFT via NFC — no crypto wallet setup required. The Tangem Card handles the wallet infrastructure, making Web3 genomics accessible to non-crypto-native consumers.
  • Magic (Google OAuth Bridge)secondaryTechnology or IntegrationMagic provides OAuth-to-Web3 authentication bridge enabling users to sign in with their Google account, which Magic converts to a Web3 wallet. Supports MetaMask, GenoBank BioWallet, and Magic for wallet-based authentication. Reduces friction for non-crypto-native users onboarding to the platform.
  • Coinbase (x402 Protocol)secondaryTechnology or IntegrationCoinbase's x402 HTTP-native payment protocol enables agent-to-agent micropayments for genomic data access and analysis across the decentralized biobank network. The x402 BioData Router provides Byzantine-fault-tolerant quality assurance for automated data commerce between AI agents and data providers.
  • NiMEDix (Nigeria)minorStrategic or Co-development PartnerNiMEDix is a Nigerian blockchain/AI company focused on bridging gaps in remittances, healthcare funding collaboration, and healthcare access services. Announced June 2021 as a strategic partnership for healthcare blockchain expansion in Africa.
  • Bustamante Lab (Florida)minorStrategic or Co-development PartnerBustamante Lab is a research and development laboratory in Hialeah, Florida. Announced as a GenoBank.io partnership in June 2021 for blockchain-enabled laboratory services and COVID-19 testing verification.
  • Government of Quintana Roo (Mexico)minorStrategic or Co-development PartnerGenoBank.io partnered with the Government of the State of Quintana Roo, Mexico to verify authenticity of COVID-19 test results using the Avalanche blockchain platform. Combatting test fraud was the primary use case for this government partnership.

Scale indicators12 records

Recent moves6 records

Expansion highlights7 records

Genobank.io competitors and assessment

Company assessment

Broad incumbents

  • AncestryDNA: World's largest consumer DNA network with 20M+ users, focused on genealogy and increasingly health. Listed by GenoBank.io as a recognized DTC data source; competes for the same consumer genomic-data mindshare that GenoBank.io targets.
  • 23andMe: Pioneer in direct-to-consumer genetic testing with a massive consented database. GenoBank.io itself lists 23andMe as a recognized data source in its GenoBank catalog, positioning it as both a competitor (DTC genomics) and an integration partner for legacy data portability.
  • Invitae: Leading medical genetics company offering clinical-grade genetic testing across multiple specialties. Listed in GenoBank.io's DTC ecosystem and shares the same CLIA-certified lab ecosystem that GenoBank.io's LabNFT infrastructure verifies on-chain.

Direct peers

  • Dante Labs: Whole-genome sequencing provider selling DTC WGS kits internationally. Listed in GenoBank.io's recognized data catalog; competes for the same price-conscious WGS consumer that GenoClaw targets with 30x WES at $499.
  • Nebula Genomics: Whole-genome sequencing DTC company co-founded by George Church that emphasizes privacy-preserving, blockchain-based access to genomic data. Closest direct comparator to GenoBank.io given its explicit use of blockchain for genomic data control and similar WGS + AI-agent positioning.
  • Veritas Genetics: Whole-genome sequencing provider with explicit positioning around consumer ownership of genetic data. Listed as a recognized GenoBank.io data source; competes in the premium WGS tier that GenoClaw Kit Edition 01 also targets.

Emerging players

  • FamilyTreeDNA: Genetic genealogy and ancestry testing company. Listed in GenoBank.io's recognized data catalog; competes for the same ancestry-curious consumer that SOMOS DAO serves.
  • Color Genomics: Clinical-grade genetic testing company offering hereditary cancer, cardiovascular, and pharmacogenomics panels. Competes for the same health-conscious consumer segment that GenoClaw Kit positions for cancer-risk and PGx skills.
  • Helix DNA: DTC genomics platform with an app-driven DNA marketplace model. Listed in GenoBank.io's recognized catalog and shares the marketplace-style approach to genomic data applications.

Regional players

  • MyHeritage DNA: Genetic testing service with strong European user base and family-tree integrations. Comparable to GenoBank.io's international lab network ambition and a likely data-import target for GenoVault users outside the US Edition 01 footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks7 records

Key highlights7 records

Customer concentration

Genobank.io social profiles

Digital presence

Genobank.io compliance and trust

Trust signal

Compliance14 records

Genobank.io financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Genobank.io leadership team

Management profile

Number of profiles

Profiles1 record

Genobank.io funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Genobank.io M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genobank.io

What does Genobank.io do?

GenoBank.io operates a patient-owned genomic data platform that converts physical DNA samples into patented BioNFTs (US Patents 11,984,203 B1 and 11,915,808 B1) on its Sequentia Layer-1 blockchain, enabling patients to control, license, and revoke access to their genetic data. The company sells a direct-to-consumer GenoClaw DNA Kit ($499 pre-sale) that includes 30x whole-exome sequencing, a local AI agent, and Tangem NFC wallet, plus a $9/month Cloud BioVault subscription. It also offers laboratory certificates, partner lab onboarding (52 organizations across 8+ countries), and Story Protocol-based BioIP licensing to researchers.

Is Genobank.io a public or private company?

Genobank.io is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Genobank.io founded?

Genobank.io was founded in 2020. It employs 1 to 10 people.

Where is Genobank.io based?

Genobank.io is headquartered in San Mateo, United States, in the North America region.

How does Genobank.io make money?

Four revenue lines are on record. GenoClaw DNA Kit Sales are the primary driver. The others are cloud BioVault Subscription, story Protocol Genomic IP Licensing and x402 BioData Router Micropayments.

Who are Genobank.io's main competitors?

Broad incumbents on record are AncestryDNA, 23andMe and Invitae. Direct peers are Dante Labs, Nebula Genomics and Veritas Genetics. Emerging players are FamilyTreeDNA, Color Genomics and Helix DNA. MyHeritage DNA is listed as a regional player.

Does Genobank.io have an API?

Yes. Genobank.io exposes a public API. Developer documentation is at genobank.app/docs.

What industry is Genobank.io in?

Genobank.io's product category is Blockchain Genomics Platform. Its primary akta.pro industry code is HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics), with a secondary code of HLALAHAK, Genetic Counseling & Prenatal Testing Telehealth (carrier screening, NIPT counseling). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
스타트업엔(StartupN)윤회(CARE ID), 118억 국가 R&D 합류… ‘EU 디지털제품여권’ 섬유 데이터 인프라 구축 나선다Yunhwa (CARE ID) joined a 11.8 billion won national R&D project to build Korean textile data infrastructure for the EU Digital Product Passport. The project, running 2026-2030, aims to cut carbon footprints by over 30% and create a K-DPP model. Success depends on data standardization and applicability across supply chain companies.FreelimsTop 10 Genomics Trends & Technologies: Stay Ahead with a Genomics LIMSThe article outlines ten key trends shaping the genomics industry in 2025, including multiomics integration, AI-driven analysis, next-generation sequencing advancements, and genome editing technologies like CRISPR. It highlights specific technological developments such as Google DeepMind's AlphaFold 3, portable sequencing by Oxford Nanopore, and decentralized data platforms like Genobank.io to enhance research and clinical diagnostics. The piece concludes by emphasizing the critical role of Laboratory Information Management Systems (LIMS) in managing complex genomic data workflows and ensuring regulatory compliance.Refresh MiamiTwo Silicon Valley genomic data experts announce partnership in MiamiGenoBank.io announced a partnership with Bustamante Lab, Inc. to develop a platform for sequencing SARS-CoV-2 while ensuring participant data privacy through blockchain-based BioNFTs. Dr. Carlos D. Bustamante leads the research initiative after leaving Stanford University, aiming to monitor virus variants and understand their impact on infected individuals.CoinJournalCovid Travel Tests To Be Stored On BlockchainGenoBank.io has partnered with Arion Genetica and Mexico City laboratories to store COVID-19 test results on a public blockchain, aiming to prevent fraud and verify authenticity for international travelers. The system uses cryptographic signatures and immutable records to ensure lab results are tamper-proof and private while allowing border authorities to validate them efficiently.PR NewswireGenoBank.io y Arion Genetica se asocian para hacer que la prueba viral de COVID-19 sea más fácil y segura para los viajerosGenoBank.io has partnered with Arion Genetica and a network of laboratories in Mexico City to cryptographically verify COVID-19 test results for travelers and prevent fraud. The companies are leveraging blockchain technology to create a verifiable chain of custody for laboratory results, which are encrypted and stamped on a public blockchain with a 3-day validity window accessible via QR code. The certified results are accepted by the U.S. Department of Homeland Security to streamline border entry and reduce fraud risks for travelers heading to the United States.PR NewswireGenoBank.io and Arion Genetica Partner to Make COVID-19 Testing Easier, More Secure for TravelersGenoBank.io has partnered with Arion Genetica to provide blockchain-based COVID-19 test verification for travelers entering the United States. The technology encrypts and records lab results on a public blockchain, creating a verifiable chain of custody to prevent test result fraud. The certified results are accepted by the U.S. Department of Homeland Security to streamline the testing process and minimize risk for travelers.PR NewswireGenobank Surpasses $418K in Crowdfunding to Launch the First Ever Anonymous DNA Test KitGenobank.io has raised $418,000 in equity crowdfunding from over 1,400 investors to launch its anonymous DNA test kit. The company also received a $50,000 grant from Block.one to facilitate anonymous access to COVID-19 testing using its privacy-preserving technology.CoinTelegraphBlockchain Firms Team Up on Private Coronavirus Testing AppGenobank partnered with Telos to develop Agerona, an app for anonymous coronavirus testing on the Telos blockchain. The app stores test data on the blockchain and allows users to share results with healthcare organizations. Launch is expected this month, with plans for AI-based diagnostic tools.